DOCSLIB.ORG

Syllabus and Proceedings Advances in Medicine Each Year in Medical Treatment and Lost Productivity

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Syllabus and Proceedings Advances in Medicine Each Year in Medical Treatment and Lost Productivity Syllabus and Proceedings Advances in Medicine each year in medical treatment and lost productivity. Further, as the public health crisis of prescription Saturday, May 20, 2017 drug abuse continues to grip the nation, the need to understand the biology of pain and the risks and Medical Mysteries and Practical Med Psych benefits of various pain treatments becomes critical. Updates: Is It “Medical,” “Psychiatric” or a Little of Despite these alarming concerns, few resources have Both...? been dedicated to study pain. Pain is the least Chair: Robert McCarron, D.O. studied phenomenon at the National Institutes of Presenters: Pritham Raj, M.D., Jeremy DeMartini, Health (NIH), yet the most common reason patients Glen Xiong, M.D., Matthew Reed, M.D. proceed to the emergency room seeking care. Moreover, many studies have documented EDUCATIONAL OBJECTIVE: substantial deficits regarding pain education in many 1) Better understand the interplay between general pre-licensure curricula in various health fields. medical conditions and abnormal or maladaptive Essential to the assessment of chronic pain is a behavior; 2) Discuss both common and less common detailed working knowledge of the biopsychosocial psychiatric presentations of frequently encountered model and the influence of mood on pain and vice general medical conditions; and 3) Review “up to versa. The following dynamic discussion will allow date” and evidence-based practice patterns for for a brief but important review of how pain figures medical/psychiatric conditions. into the model and the critical relationship between mood and pain. Next, we will address novel SUMMARY: therapies that address both mood and pain and dive Psychiatrists often encounter clinical scenarios that into the complex phenomenon of how we physically may not have a clear explanation. The Medical respond and experience pain. Finally, we will review Mysteries faculty practice both internal medicine the most salient points regarding rational and psychiatry and will collaborate with the polypharmacy and specific treatment strategies that audience to review several case-based "medical may prove useful for patients suffering from chronic mysteries." A relevant and concise update on several pain. "Med Psych" topics will be discussed. A focus will be placed on covering general medical topics that are Top 10 Medical Stories 2016: A Practical and particularly important to the practice of psychiatry. Comprehensive Review of What We Need to Know Chair: Monique Yohanan, M.D. Pain Medicine and Psychiatry Presenter: David J. Copenhaver, M.D., M.P.H. EDUCATIONAL OBJECTIVE: 1) Review the key medical literature from 2016 with EDUCATIONAL OBJECTIVE: a special focus on stories that are newsworthy and 1) Describe the biopsychosocial model and the likely to impact clinical practice; 2) Provide an relationship to pain; 2) Describe the effect of pain on appraisal of the quality of the evidence supporting mood; 3) Describe the effect of mood on pain and literature selected for inclusion; and 3) Emphasize pain tolerance; 4) Describe novel therapies that disease and lifestyle factors that are associated with address pain and mood; and 5) Compare rational an increase in cardiovascular risk. polypharmacy to other treatment methods. SUMMARY: SUMMARY: The medical treatment of people with psychiatric In the report "Relieving Pain in America," published conditions is essential to optimal care. Disparities in in June of 2011, the Institute of Medicine provided morbidity and mortality for psychiatric patients are shocking insight into pain care in the United States. often related to medical diseases, in particular, The Institute of Medicine report described eye- cardiovascular disease. Cardiovascular diseases and opening statistics stating over 100 million Americans cardiovascular risk factors including diabetes, suffer from chronic pain, with a cost of $635 billion hypertension and hyperlipidemia are common in people with psychiatric diagnoses. In addition, Gunderson, M.D., Mardi Horowitz, M.D. behavioral health factors, such as sedentary lifestyle, impact psychiatric patients in a disparate fashion. EDUCATIONAL OBJECTIVE: This session presents the top 10 medical stories of 1) Illustrate how to use psychodynamic 2016. Selected articles represent topics that are both psychotherapy in PTSD patients; 2) Treat narcissistic newsworthy and likely to impact clinical practice. personality disorder with dynamic therapy; 3) Learn Each publication selected will include an overview of about therapeutic processes in managing BPD the quality of the evidence. patients; 4) Understand when transference work in indicated in dynamic psychotherapy; and 5) Identify Monday, May 22, 2017 and treat resistance in psychodynamic psychotherapy. Using Technology to Help Your Practice: A Practical Overview SUMMARY: Chair: John Luo, M.D. This session will provide an overview of long-term psychodynamic psychotherapy in present-day EDUCATIONAL OBJECTIVE: practice. Dr. Robert Michels will elaborate on the 1) Incorporate appropriate security measures with concept of resistance and how it can be successfully smartphones and computers to maintain and usefully incorporated into the therapy setting. confidentiality of health information; 2) Recognize Dr. Mardi Horowitz will discuss PTSD and its security risks of phishing attacks and avoid malware; treatment. He will cover the current controversies 3) Appropriately utilize social media for marketing about the role of exposure in the treatment and and outreach to patients; 4) Assess their online e- describe his research on using psychodynamic reputation and implement strategies to improve therapy as an alternative to exposure treatment. Dr. reputation; and 5) Assess smartphone applications Eve Caligor will illustrate a transference-focused for use with patients. psychodynamic therapy for narcissistic personality disorder. Dr. John Gunderson will show how to apply SUMMARY: good psychiatric management to BPD and present Technology use today touches almost every aspect the data suggesting that it is just as effective as of the psychiatric practice, including documentation, other empirically validated therapies for BPD. In so billing and communication. There are a great doing, he will also provide an overview of what number of Internet-based applications, including psychodynamic therapeutic processes comprise electronic medical records, social media, search good psychiatric management. Finally, Dr. Glen engines, and health information resources, that hold Gabbard will illustrate the role that transference both great potential good as well as harm with work has in long-term psychodynamic regard to patient care. Smartphones and tablets as psychotherapy. He will base his recommendations well access this wealth of information, and their on the research he has been involved with in Norway “apps” show great promise to change the delivery of and at the Menninger Clinic. In all five presentations, health care. This session will cover issues of security, there will be an emphasis on how research informs privacy, connectivity, and innovation in technology the psychotherapist's interventions. Theory and use in psychiatric practice. practical clinical strategies will be discussed in terms of how one applies to the other. The continued role Advances in Psychiatry of long-term psychodynamic psychotherapy will be emphasized. To make this case, there will be Saturday, May 20, 2017 numerous references to the growing database of studies that lead to the conclusion that Advances in Long-Term Psychodynamic psychodynamic psychotherapy can be considered an Psychotherapy empirically validated entity for use in depression, Chair: Glen O. Gabbard, M.D. anxiety disorders, some personality disorders. Presenters: Eve Caligor, M.D., Robert Michels, John patients who have been traumatized, and those who come to therapy with an uncertain view of their elective surgery? Which psychiatric drugs cause condition and what it is they are seeking. Each osteoporosis? Time will be allotted to answer presenter will provide brief case examples where the audience members’ questions. mechanism of action can be illustrated, and the decision-making regarding what intervention is most Sunday, May 21, 2017 helpful will be discussed as well. A central feature of long-term psychodynamic therapy is that each The New Motivational Interviewing of 2017: Learn individual is unique, and the therapeutic approach the Essentials, Practice Your Skills and Help Your has to be adjusted to who the patient is and what Patients Change the patient wants and needs. There will also be Chairs: Petros Levounis, M.D., Carla Marienfeld, M.D. discussion of how one prepares the patient for long- Presenters: Natassia Gaznick, Bachaar Arnaout term psychodynamic psychotherapy, both in terms of postulated mechanisms of action and what role EDUCATIONAL OBJECTIVE: the patient has to play in making the therapy 1) Describe the new terminology for the spirit and effective. The presenters will provide ample time for processes of motivational interviewing (MI) based on discussion with the audience so questions and the third edition of Motivational Interviewing; 2) concerns can be considered. Each of the presenters Practice the four processes of motivational will also have the opportunity to respond to other interviewing in interactive small- and large-group presenters' lectures. Dr. Glen Gabbard will chair and formats; and 3) Discuss the rationale for using the serve as the moderator of the entire session in
Load more

Recommended publications
  • The Informant Issue10v2
    The Friedman Brain Institute is proud to present the 10th issue of the FBI Informant. The Informant is a triennial newsletter highlighting announcements and events for basic and clinical neuroscience at Mount Sinai. The purpose of riedman rain nstitute the Informant is to keep everyone abreast of all that is going on in and out of the F B I labs and clinics that comprise the Friedman Brain Institute, as well as acknowledge those individuals responsible for its success. In addition to sharing the information, our hope is that the Informant can be used as a tool to inspire, informant congratulate, and support one another. Announcements 5th Annual Neuroscience Retreat While exciting science and the exchange of information form the centerpiece of the Friedman Brain Institute’s Annual Neuroscience Retreat, it is the participation and social interactions of the various departments that make these retreats so effective and enjoyable. This year’s retreat took place on Friday, April 26th, 2013 at the New York Academy of Medicine. The morning session included a April 26, 2013 New York Academy of Medicine 1216 Fifth Avenue Dr. Daniela Schiller Geoffrey W. Smith Lauren Friedman stirring talk from Eric Nestler, director of the Friedman Brain Keynote Speaker Guest Speaker Guest Speaker Assistant!Professor of Director, President, Psychiatry and Center for Technology, Sinai Neuroscience Neuroscience Innovation and Outreach Program “SNOP” Institute and chair of Neuroscience Department. Dr. Nestler Entrepreneurship highlighted the successes of the Friedman Brain Institute and the 5th Annual Neuroscience Retreat presented ideas for the path forward. Friedman Brain Institute and the Neuroscience Training Area Keynote speaker Daniela Schiller gave a thought-provoking lecture about her group’s work aimed at understanding how the brain handles social interaction tasks.
    [Show full text]
  • Methamphetamine & Opioid Response Initiative
    Billings Metro VISTA Project Methamphetamine & Opioid Response Initiative: A Community Assessment July 2019 AmeriCorps VISTAs: Nick Fonte and Amy Trad Table of Contents EXECUTIVE SUMMARY ......................................................................................................................................... 3 INTRODUCTION ....................................................................................................................................................... 4 Section 1: Area of Study ............................................................................................................................................ 4 Section 2: Methamphetamine vs. Opioids ................................................................................................................. 5 KEY STAKEHOLDERS ............................................................................................................................................ 6 Section 1: Community Organizations/Non-profits .................................................................................................... 6 Section 2: Statewide and Local Initiatives ................................................................................................................ 9 RELEVANT DATA ................................................................................................................................................... 11 Section 1: Methamphetamine and Opioids in the News .........................................................................................
    [Show full text]
  • Getting Through Amphetamine Withdrawal – a Guide for People
    Amphetamine_wdl_220404.qxd 28/04/2004 12:19 PM Page i GETTING THROUGH AMPHETAMINE WITHDRAWAL A guide for people trying to stop amphetamine use Amphetamine_wdl_220404.qxd 28/04/2004 12:19 PM Page ii GETTING THROUGH AMPHETAMINE WITHDRAWAL CONTENTS About this book x Making the decision to stop using amphetamines x Amphetamine withdrawal x What is withdrawal? x How long will the symptoms last? What kinds of symptoms will I have? x Getting started x Organise a safe environment x Organise support x Structure your day x The role of medication x Getting through withdrawal x Cravings x Sleep x September 1996 Relaxing x Revised May 2004 Mood swings x © Turning Point Alcohol and Drug Centre Inc. Strange thoughts x 54-62 Gertrude Street, Fitzroy VIC 3065 Eating again x T: 03 8413 8413 Aches and pains x F: 03 9416 3420 High-risk situations x Counselling x E: [email protected] It’s all too much x www.turningpoint.org.au Sex and withdrawal x Original edition by Dr Nik Lintzeris, Dr Adrian Dunlop and After withdrawal x David Thornton What next? x Updated (2004) by Dr Adrian Dunlop, Sandra Hocking, Dr Getting back on track if you ‘slip up’ x Nicole Lee and Peter Muhleisen Notes for supporters x Cartoonist: Mal Doreian Useful contact numbers x ISBN 0_958 6979_1_4 1 Amphetamine_wdl_220404.qxd 28/04/2004 12:19 PM Page 2 GETTING THROUGH AMPHETAMINE WITHDRAWAL MAKING THE DECISION TO STOP USING AMPHEATMINES ABOUT THIS BOOK This book is written for people who are thinking about You may find it helpful to make a list of the positives and the or trying to stop using amphetamines, even if just for a negatives about using amphetamines.
    [Show full text]
  • ENIGMA and the Individual: Predicting Factors That Affect the Brain in 35 Countries Worldwide☆,☆☆,★
    NeuroImage 145 (2017) 389–408 Contents lists available at ScienceDirect NeuroImage journal homepage: www.elsevier.com/locate/ynimg ENIGMA and the individual: Predicting factors that affect the brain in 35 countries worldwide☆,☆☆,★ Paul M. Thompson a,s, Ole A. Andreassen b,c, Alejandro Arias-Vasquez d, Carrie E. Bearden e,f,g, Premika S. Boedhoe h,bk,bl, Rachel M. Brouwer i,RandyL.Bucknerj, Jan K. Buitelaar k,l,KazimaB.Bulayevam, Dara M. Cannon n,o, Ronald A. Cohen p, Patricia J. Conrod q,AndersM.Daler, Ian J. Deary t, Emily L. Dennis a, Marcel A. de Reus i, Sylvane Desrivieres u, Danai Dima v,w, Gary Donohoe x,SimonE.Fishery,k, Jean-Paul Fouche z, Clyde Francks y,k, Sophia Frangou w, Barbara Franke aa,ab,k,HabibGanjgahiac, Hugh Garavan ad, David C. Glahn ae,af,HansJ.Grabeag,ah, Tulio Guadalupe y,ai, Boris A. Gutman a, Ryota Hashimoto aj,DerrekP.Hibara, Dominic Holland r, Martine Hoogman aa,k, Hilleke E. Hulshoff Pol i, Norbert Hosten ak, Neda Jahanshad a, Sinead Kelly a,PeterKochunoval, William S. Kremen am,PhilH.Leean,ao,ap, Scott Mackey aq, Nicholas G. Martin as, Bernard Mazoyer ar,ColmMcDonaldo, Sarah E. Medland as, Rajendra A. Morey at, Thomas E. Nichols au,av,TomasPausaw,ax,ay,ZdenkaPausovaaz,ba, Lianne Schmaal bk,bl, Gunter Schumann u, Li Shen bb,bc, Sanjay M. Sisodiya bd, Dirk J.A. Smit be,bl,JordanW.Smollerbf,DanJ.Steinz,bg, Jason L. Stein a,bh, Roberto Toro bi, Jessica A. Turner bj, Martijn P. van den Heuvel i, Odile L. van den Heuvel h,bk,bl, Theo G.M.
    [Show full text]
  • Telomere Length and Bipolar Disorder
    King’s Research Portal DOI: 10.1038/npp.2017.125 Document Version Version created as part of publication process; publisher's layout; not normally made publicly available Link to publication record in King's Research Portal Citation for published version (APA): Powell, T., Dima, D., Frangou, S., & Breen, G. D. (2017). Telomere length and bipolar disorder. Neuropsychopharmacology . https://doi.org/10.1038/npp.2017.125 Citing this paper Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination, volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are again advised to check the publisher's website for any subsequent corrections. General rights Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights. •Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research. •You may not further distribute the material or use it for any profit-making activity or commercial gain •You may freely distribute the URL identifying the publication in the Research Portal Take down policy If you believe that this document breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim.
    [Show full text]
  • (S) Or the School Where You Work Do You Have Any Ideas Or
    Timestamp Please share your question or concern. Your student's school (s) or Do you have any ideas or suggestions for how you think we can the school where you work address this concern? If the school is closed for a number of days, will the Classified Staff get paid? if not, under this case are we able to claim unemployment. 3/3/2020 14:46:02 What about our FIT and At Risk Students for food? A parent has notified us that the child is being pulled from school (has IEP) due to Coronavirus. Is there language I should use and contacting the parent? Provide standard language/response for parents pulling students and 3/4/2020 9:06:55 how should we mark the attendance? (medical?) The aerosol cleaner that a lot of our custodians use and like is just a cleaner and not a disinfectant. (Reported to Hatton by a dray driver). Can we please direct custodians which products they can use from the CDC list and what procedures they need to use? 3/4/2020 10:48:56 from parent - What is the district doing to prepare? Parent offered to help. I referred parent to Supt. blog. This request came on Sunday, 3/1 before 3/4/2020 13:29:12 parent emails went out. from parent - Parent asked - Does the school allow students to wash hands before lunch with soap and water, not just hand sanitizer? I answered that we do allow them to stop by the bathroom before entering the lunch room. Rattlesnake is also creating a hand washing video to show school-wide as part of the Principal Monday Message.
    [Show full text]
  • Pan American Division Newsletter
    Royal College of Psychiatrists Pan American Division Newsletter April 2018 (Issue 40) Dear Colleagues Following the recent election, we welcome to the Division Prof. Kenneth Kaufman as Vice-hair and Prof Allan Tasman as Financial Officer. Prof. Sophia Frangou will continue in her role as chair. Prof. Kaufman is well known to all the members of the Division because of his dedicated and long-standing contribution which started with his appointment as Financial Officer and most recently as Acting Vice-Chair. Prof Tasman brings with him a wealth of experience as he has previously served as president of the American Association of Directors of Psychiatric Residency Training, of the Association for Academic Psychiatry, of the American Association of Chairs of Departments of Psychiatry, of the American Psychiatric Association, of the Pacific Rim College of Psychiatrists. Together we hope that we continue to enrich the work of the Division and address the needs and aspirations of its members. The College has a very significant presence this year at the annual meeting of the American Psychiatric Association (APA). The meeting is taking place at the Javits Center in New York city, between the 5th and 9th of May. Please mark your diaries! Saturday May 05th, 8:00am–11:00am, Room 1A14 (First Level), Javits Center, 655 West 34th Street, New York Session Title: Body-Behavior-Brain Interactions in Psychosis (Session ID: 2017) Chair/presenter: Professor Sophia Frangou, (Icahn School of Medicine at Mount Sinai) Chair/presenter: Matcheri S. Keshavan (Harvard Medical School) Presenter: Christoph U. Correll (Donald and Barbara Zucker School of Medicine at Hofstra/Northwell) Presenter: Professor Swaran Singh (University of Warwick, UK) The presentations of this symposium summarize the current knowledge about the nature and prevalence of metabolic and glycemic dysregulation in psychosis, its association to medication, its effect on neuroimaging phenotypes and its implication for care planning and service provision.
    [Show full text]
  • Cocaine Use in Ireland: an Exploratory Study
    Cocaine Use In Ireland: An Exploratory Study Chapter 3 Cocaine Use In Ireland: An Exploratory Study Paula Mayock 3.1 Introduction In Ireland the heroin epidemic of the 1980s, coupled with the public health crisis of HIV transmission through unsafe injecting practices, resulted in a concentration of attention on 'high-risk' drug use categories, most notably heroin and other intravenous drug use. The major focus in the domains of drug policy, treatment and research centred on the 'threats' posed by enduring patterns of drug use, unsafe methods of drug administration and associated risk behaviours. Heroin, being a dominant drug of misuse among individuals receiving treatment, certainly in the greater Dublin area (O'Brien, Moran, Kelleher & Cahill, 2000), has attracted by far the greatest level of interest and attention. This situation is by no means unique to Ireland. As Egginton & Parker (2000) have remarked, 'so distinctive is the impact of this drug that heroin has its own epidemiology' (Egginton & Parker, 2000: 7). In practice, prevalence studies and other empirical research focus on groups, such as opiate users or injectors, who are of concern at a particular time (Frischer & Taylor, 1999). Put differently, attention to particular forms of drug use is very much a function of the drug- political situation in any given jurisdiction (Cohen, 1996). Despite heroin's prominence, publicity and official concern, the past decade has witnessed increased recognition of the pervasiveness of drug use in society generally. Drug use, traditionally associated with social and economic disadvantage, is increasingly recognised as a widespread social phenomenon and is clearly no longer confined to marginalised communities.
    [Show full text]
  • Identification and Brief Treatment Approaches for Substance Use Disorders the Care Transitions Network
    Identification and Brief Treatment Approaches for Substance Use Disorders The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental Health Netsmart Technologies Presenters Dr. George C. Nitzburg, Research Scientist Dr. Nehal P. Vadhan, Assistant Investigator Center for Addiction Services and Personalized Interventions Research (CASPIR), Departments of Psychiatry and Molecular Medicine Hofstra Northwell School of Medicine Feinstein Institute for Medical Research Objectives • At the completion of this webinar, attendees will be able to: 1. Identify the characteristics of patients who are misusing substances, including alcohol, cannabis, and opioids 2. Know how to assess for substance use disorders, including differential diagnosis from bipolar and schizophrenia and recognizing co-occurring disorders 3. Describe treatment approaches substance use disorders, including alcohol, cannabis, and opioids What is your role? What is your primary role in your organization? A. Administrator B. Prescribing Clinician C. Non-prescribing clinician D. Researcher E. Other Outline • Overview of substance use • Identification of substance use disorders (SUD) • Treating SUDs • Alcohol • Cannabis (natural and synthetic) • Opiates Overview: Understanding Substance Use • Why use drugs? • Well-liked, and with few exceptions, we all use them (e.g., aspirin, caffeine) • Which drugs, and how much (e.g., alcohol), is what makes all the difference • Drugs induce positive feeling states
    [Show full text]
  • Telomere Length As a Predictor of Emotional Processing in the Brain
    King’s Research Portal DOI: 10.1002/hbm.24487 Document Version Publisher's PDF, also known as Version of record Link to publication record in King's Research Portal Citation for published version (APA): Powell, T. R., De Jong, S., Breen, G., Lewis, C. M., & Dima, D. (2018). Telomere length as a predictor of emotional processing in the brain. Human Brain Mapping. https://doi.org/10.1002/hbm.24487 Citing this paper Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination, volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are again advised to check the publisher's website for any subsequent corrections. General rights Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights. •Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research. •You may not further distribute the material or use it for any profit-making activity or commercial gain •You may freely distribute the URL identifying the publication in the Research Portal Take down policy If you believe that this document breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim.
    [Show full text]
  • IDENTIFYING EXOPLANETS with DEEP LEARNING II: TWO NEW SUPER-EARTHS UNCOVERED by a NEURAL NETWORK in K2 DATA Anne Dattilo1,†, Andrew Vanderburg1,?, Christopher J
    Preprint typeset using LATEX style emulateapj v. 12/16/11 IDENTIFYING EXOPLANETS WITH DEEP LEARNING II: TWO NEW SUPER-EARTHS UNCOVERED BY A NEURAL NETWORK IN K2 DATA Anne Dattilo1,y, Andrew Vanderburg1,?, Christopher J. Shallue2, Andrew W. Mayo3,z, Perry Berlind4, Allyson Bieryla4, Michael L. Calkins4, Gilbert A. Esquerdo4, Mark E. Everett5, Steve B. Howell6, David W. Latham4, Nicholas J. Scott6, Liang Yu7 ABSTRACT For years, scientists have used data from NASA's Kepler Space Telescope to look for and discover thousands of transiting exoplanets. In its extended K2 mission, Kepler observed stars in various regions of sky all across the ecliptic plane, and therefore in different galactic environments. Astronomers want to learn how the population of exoplanets are different in these different environments. However, this requires an automatic and unbiased way to identify the exoplanets in these regions and rule out false positive signals that mimic transiting planet signals. We present a method for classifying these exoplanet signals using deep learning, a class of machine learning algorithms that have become popular in fields ranging from medical science to linguistics. We modified a neural network previously used to identify exoplanets in the Kepler field to be able to identify exoplanets in different K2 campaigns, which range in galactic environments. We train a convolutional neural network, called AstroNet-K2, to predict whether a given possible exoplanet signal is really caused by an exoplanet or a false positive. AstroNet-K2 is highly successful at classifying exoplanets and false positives, with accuracy of 98% on our test set. It is especially efficient at identifying and culling false positives, but for now, still needs human supervision to create a complete and reliable planet candidate sample.
    [Show full text]
  • 40Th FREE with Orders Over
    By Appointment To H.R.H. The Duke Of Edinburgh Booksellers London Est. 1978 www.bibliophilebooks.com ISSN 1478-064X CATALOGUE NO. 366 OCT 2018 PAGE PAGE 18 The Night 18 * Before FREE with orders over £40 Christmas A 3-D Pop- BIBLIOPHILE Up Advent th Calendar 40 with ANNIVERSARY stickers PEN 1978-2018 Christmas 84496, £3.50 (*excluding P&P, Books pages 19-20 84760 £23.84 now £7 84872 £4.50 Page 17 84834 £14.99 now £6.50UK only) 84459 £7.99 now £5 84903 Set of 3 only £4 84138 £9.99 now £6.50 HISTORY Books Make Lovely Gifts… For Family & Friends (or Yourself!) Bibliophile has once again this year Let us help you find a book on any topic 84674 RUSSIA OF THE devised helpful categories to make useful you may want by phone and we’ll TSARS by Peter Waldron Including a wallet of facsimile suggestions for bargain-priced gift buying research our database of 3400 titles! documents, this chunky book in the Thames and Hudson series of this year. The gift sections are Stocking FREE RUBY ANNIVERSARY PEN WHEN YOU History Files is a beautifully illustrated miracle of concise Fillers under a fiver, Children’s gift ideas SPEND OVER £40 (automatically added to narration, starting with the (in Children’s), £5-£20 gift ideas, Luxury orders even online when you reach this). development of the first Russian state, Rus, in the 9th century. tomes £20-£250 and our Yuletide books Happy Reading, Unlike other European countries, Russia did not have to selection.
    [Show full text]